News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,604 Results
Type
Article (41546)
Company Profile (272)
Press Release (681776)
Multimedia
Podcasts (83)
Webinars (18)
Section
Business (205131)
Career Advice (2053)
Deals (35605)
Drug Delivery (113)
Drug Development (81535)
Employer Resources (173)
FDA (16482)
Job Trends (14982)
News (347219)
Policy (32841)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2588)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49682)
ALS (168)
Alzheimer's disease (1662)
Antibody-drug conjugate (ADC) (305)
Approvals (16747)
Artificial intelligence (501)
Autoimmune disease (144)
Automation (37)
Bankruptcy (363)
Best Places to Work (11666)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (178)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (631)
Cancer (4757)
Cardiovascular disease (397)
Career advice (1732)
Career pathing (35)
CAR-T (275)
CDC (44)
Celiac Disease (2)
Cell therapy (728)
Cervical cancer (36)
Clinical research (69581)
Collaboration (1669)
Company closure (4)
Compensation (1138)
Complete response letters (54)
COVID-19 (2721)
CRISPR (88)
C-suite (811)
Cystic fibrosis (143)
Data (6148)
Decentralized trials (2)
Denatured (27)
Depression (131)
Diabetes (495)
Diagnostics (6672)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (241)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (227)
Earnings (90190)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117492)
Executive appointments (961)
FDA (19561)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1449)
Gene editing (192)
Generative AI (42)
Gene therapy (585)
GLP-1 (965)
Government (4672)
Grass and pollen (6)
Guidances (383)
Healthcare (18930)
HIV (55)
Huntington's disease (45)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (54)
Indications (103)
Infectious disease (2979)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (319)
IPO (16674)
IRA (49)
Job creations (3654)
Job search strategy (1449)
JPM (57)
Kidney cancer (15)
Labor market (83)
Layoffs (551)
Leadership (30)
Legal (7986)
Liver cancer (91)
Longevity (14)
Lung cancer (638)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (779)
MASH (161)
Medical device (13888)
Medtech (13940)
Mergers & acquisitions (19987)
Metabolic disorders (1251)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (313)
Neuropsychiatric disorders (87)
Neuroscience (2883)
Neurotech (1)
NextGen: Class of 2026 (6550)
Non-profit (4536)
Now hiring (65)
Obesity (587)
Opinion (256)
Ovarian cancer (164)
Pain (198)
Pancreatic cancer (222)
Parkinson's disease (280)
Partnered (33)
Patents (487)
Patient recruitment (469)
Peanut (55)
People (58948)
Pharmaceutical (64)
Pharmacy benefit managers (29)
Phase 1 (21704)
Phase 2 (30619)
Phase 3 (22813)
Pipeline (5079)
Policy (279)
Postmarket research (2570)
Preclinical (9230)
Press Release (64)
Prostate cancer (235)
Psychedelics (47)
Radiopharmaceuticals (279)
Rare diseases (817)
Real estate (5975)
Recruiting (69)
Regulatory (24480)
Reports (51)
Research institute (2395)
Resumes & cover letters (357)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (238)
Series B (185)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (178)
Sponsored (41)
Startups (3630)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (54)
Vaccines (986)
Venture capital (87)
Weight loss (377)
Women's health (87)
Worklife (18)
Date
Today (8)
Last 7 days (592)
Last 30 days (2195)
Last 365 days (29832)
2026 (2817)
2025 (30220)
2024 (35262)
2023 (40142)
2022 (51280)
2021 (55818)
2020 (54218)
2019 (46707)
2018 (35161)
2017 (32239)
2016 (31644)
2015 (37710)
2014 (31446)
2013 (26527)
2012 (28756)
2011 (29406)
2010 (27431)
Location
Africa (743)
Alabama (85)
Alaska (7)
Arizona (306)
Arkansas (13)
Asia (39315)
Australia (6453)
California (11161)
Canada (3249)
China (1083)
Colorado (472)
Connecticut (470)
Delaware (332)
Europe (84919)
Florida (1660)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (851)
India (62)
Indiana (515)
Iowa (22)
Japan (417)
Kansas (125)
Kentucky (38)
Louisiana (27)
Maine (72)
Maryland (1370)
Massachusetts (7997)
Michigan (320)
Minnesota (622)
Mississippi (6)
Missouri (126)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2967)
New Mexico (28)
New York (2942)
North Carolina (1436)
North Dakota (8)
Northern California (5437)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2254)
Puerto Rico (22)
Rhode Island (47)
South America (1122)
South Carolina (65)
South Dakota (1)
Southern California (4343)
Tennessee (172)
Texas (1719)
United States (39574)
Utah (334)
Vermont (1)
Virginia (257)
Washington D.C. (81)
Washington State (913)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
723,604 Results for "spinal elements inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuroscience
NervGen’s Peptide Achieves Nervous System Repair in Phase II Spinal Cord Injury Study
NervGen will meet with the FDA early next year to align on a regulatory path forward for NVG-291 in chronic spinal cord injury.
November 24, 2025
·
2 min read
·
Tristan Manalac
Approvals
Novartis Expands Spinal Muscular Atrophy Gene Therapy Market With FDA’s Itvisma Greenlight
The FDA approved an intrathecal form of Novartis’ spinal muscular atrophy gene therapy Zolgensma on Monday, broadening access to patients two years and older in what one Stanford Medicine professor called a “game changing advance” for the field.
November 25, 2025
·
3 min read
·
Heather McKenzie
Press Releases
The Reeve Foundation and Spinal Research Award New Grants to Advance Traumatic Spinal Cord Injury Treatments
January 7, 2026
·
7 min read
Press Releases
ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion
January 13, 2026
·
4 min read
Press Releases
First-of-its-kind Universal Clearance Establishes Maximum Regulatory Access to the Bezier Parametric Curve Spinal Rod System for Patients and Surgeons
February 5, 2026
·
2 min read
Press Releases
Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy
February 4, 2026
·
10 min read
Press Releases
Hollister Incorporated Drives Major Policy Change to Expand Access to Closed System Intermittent Catheters for People with Spinal Cord Injuries
November 24, 2025
·
3 min read
Press Releases
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
January 13, 2026
·
13 min read
Press Releases
Nivalon Medical Produces the World’s First Fully Patient-Specific, Motion-Preserving, Metal-Free Spinal Implant Using AI and Advanced Ceramic 3D Printing
January 30, 2026
·
6 min read
Press Releases
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
February 4, 2026
·
7 min read
1 of 72,361
Next
